Endogenous epinephrine protects against obesity induced insulin resistance

Auton Neurosci. 2011 Jul 5;162(1-2):32-4. doi: 10.1016/j.autneu.2011.01.009. Epub 2011 Feb 26.

Abstract

Epinephrine (E) is a hormone released from the adrenal medulla in response to low blood sugar and other stresses. E and related β2-adrenergic agonists are used to treat asthma, but a side effect is high blood sugar. C57BL/6 mice prone to overfeeding induced type II diabetes had the PNMT gene knocked out to prevent E synthesis. These E deficient mice were very similar to control animals on a 14% fat diet. On a 40.6% fat diet they gained 20 to 33% more weight than control animals and increased their blood glucose response to a glucose tolerance test because they became resistant to insulin. Although the short term effect of β2-agonists such as E is to raise blood glucose, some long acting β2-agonists improve muscle glucose uptake. Endogenous E protects against overfeeding induced diabetes. Since adrenal E release can be impaired with aging and diabetes, endogenous E may help prevent adult onset diabetes.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Body Weight / physiology
  • Diabetes Mellitus, Type 2 / enzymology
  • Diabetes Mellitus, Type 2 / genetics
  • Dietary Fats / pharmacology
  • Eating
  • Epinephrine / physiology*
  • Female
  • Glucose Tolerance Test
  • Insulin / blood
  • Insulin Resistance / physiology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Obesity / physiopathology*
  • Phenylethanolamine N-Methyltransferase / genetics*
  • Phenylethanolamine N-Methyltransferase / physiology*
  • Sex Characteristics
  • Weight Gain / drug effects

Substances

  • Blood Glucose
  • Dietary Fats
  • Insulin
  • Phenylethanolamine N-Methyltransferase
  • Epinephrine